Day One Biopharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DAWN and other ETFs, options, and stocks.About DAWN
Day One Biopharmaceuticals, Inc. operates as a holding company. The firm, through its subsidiary, develops and commercializes targeted therapies for patients of all ages with genetically defined cancers.
CEOJeremy Bender
CEOJeremy Bender
Employees181
Employees181
HeadquartersBrisbane, California
HeadquartersBrisbane, California
Founded2018
Founded2018
Employees181
Employees181
DAWN Key Statistics
Market cap1.24B
Market cap1.24B
Price-Earnings ratio-6.02
Price-Earnings ratio-6.02
Dividend yield—
Dividend yield—
Average volume1.34M
Average volume1.34M
High today$11.40
High today$11.40
Low today$9.70
Low today$9.70
Open price$10.76
Open price$10.76
Volume8.03M
Volume8.03M
52 Week high$13.53
52 Week high$13.53
52 Week low$5.64
52 Week low$5.64
Stock Snapshot
With a market cap of 1.24B, Day One Biopharmaceuticals(DAWN) trades at $11.06. The stock has a price-to-earnings ratio of -6.02.
On 2026-01-12, Day One Biopharmaceuticals(DAWN) stock traded between a low of $9.70 and a high of $11.40. Shares are currently priced at $11.06, which is +14.0% above the low and -3.0% below the high.
Day One Biopharmaceuticals(DAWN) shares are trading with a volume of 8.03M, against a daily average of 1.34M.
During the past year, Day One Biopharmaceuticals(DAWN) stock moved between $5.64 at its lowest and $13.53 at its peak.
During the past year, Day One Biopharmaceuticals(DAWN) stock moved between $5.64 at its lowest and $13.53 at its peak.
Analyst ratings
90%
of 10 ratingsBuy
90%
Hold
10%
Sell
0%
People also own
Based on the portfolios of people who own DAWN. This list is generated using Robinhood data, and it’s not a recommendation.